Atlas Trials

Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis

Clinical trial NCT02958917 · TERMINATED

Trial details

NCT number
NCT02958917
Sponsor
Evans Fernandez Perez
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Interstitial Lung Disease
Start date
2017-06-05
Primary completion
2021-03-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.